XML 21 R2.htm IDEA: XBRL DOCUMENT
v3.26.1

Audit Information | 12 Months Ended
--- | ---
Dec. 31, 2025
Auditor [Line Items] |
Auditor Name | KOST FORER GABBAY& KASIERER
Auditor Firm ID | 1281
Auditor Location | Tel-Aviv, Israel
Auditor Opinion [Text Block] | Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Can-Fite BioPharma Ltd. and its subsidiary (the “Company”) as of December 31, 2025 and 2024, the related consolidated statements of operating loss, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles.

X
- Definition PCAOB issued Audit Firm Identifier + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-K -Number 249 -Section 310 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 20-F -Number 249 -Section 220 -Subsection f Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 40-F -Number 249 -Section 240 -Subsection f + Details
Name: | dei_AuditorFirmId
Namespace Prefix: | dei_
Data Type: | dei:nonemptySequenceNumberItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | dei_AuditorLineItems
Namespace Prefix: | dei_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-K -Number 249 -Section 310 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 20-F -Number 249 -Section 220 -Subsection f Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 40-F -Number 249 -Section 240 -Subsection f + Details
Name: | dei_AuditorLocation
Namespace Prefix: | dei_
Data Type: | dei:internationalNameItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-K -Number 249 -Section 310 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 20-F -Number 249 -Section 220 -Subsection f Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 40-F -Number 249 -Section 240 -Subsection f + Details
Name: | dei_AuditorName
Namespace Prefix: | dei_
Data Type: | dei:internationalNameItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X -Number 210 -Section 2 -Subsection 2 + Details
Name: | dei_AuditorOpinionTextBlock
Namespace Prefix: | dei_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration